Table 1 Distribution of study treatment groups and patients across treatment categories
Treatment categories | Treatment groups | Patients | ||
|---|---|---|---|---|
N | % | N | % | |
ICS | 3 | 2.07 | 626 | 1.35 |
LABA | 51 | 35.17 | 16,059 | 34.51 |
LABA + ICS | 27 | 18.62 | 9282 | 19.95 |
LABA + LAMA | 17 | 11.72 | 5842 | 12.56 |
LAMA | 20 | 13.79 | 8618 | 18.52 |
Other | 3 | 2.07 | 299 | 0.64 |
Placebo | 24 | 16.55 | 5805 | 12.48 |
Total | 145 | 100 | 46,531 | 100 |